Tc99m Sestamibi Molecular Breast Imaging
NCT02324387
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
96
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
PROCEDURE:
Molecular Breast Imaging (MBI)
DRUG:
Tc99m sestamibi
Sponsor
M.D. Anderson Cancer Center